156 related articles for article (PubMed ID: 35116712)
1. Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion.
Shi P; Liu Y; Zhang M; Yang J; Jing S; Yang D; Liu F; Wu Y; Shi H; Geng C
Transl Cancer Res; 2021 Sep; 10(9):4158-4168. PubMed ID: 35116712
[TBL] [Abstract][Full Text] [Related]
2. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
3. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients.
Liao Y; Cheng S; Xiang J; Luo C
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1686-1692. PubMed ID: 29630113
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of lncRNA CCHE1 inhibits cell proliferation, migration and invasion by suppressing MEK/ERK/c-MYC pathway in nasopharyngeal carcinoma.
Meng XJ; Wang JC; Wang AQ; Xia WQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8880-8888. PubMed ID: 32964977
[TBL] [Abstract][Full Text] [Related]
5. Expression of long non-coding RNA CCHE1 in colorectal carcinoma: correlations with clinicopathological features and ERK/COX-2 pathway.
Gaballah HH; Gaber RA; Elrashidy MA; Elshahat DA; Hablus MA; Ebeid AM
Mol Biol Rep; 2019 Feb; 46(1):657-667. PubMed ID: 30484108
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
7. lncRNA-CCHE1 is involved in migration and invasion but not in proliferation of pancreatic adenocarcinoma cells possibly by interacting with ROCK1.
Jin X; Ye L; Lin M; Gu B; Wang J; He Y; Li W
Oncol Lett; 2019 Aug; 18(2):1218-1224. PubMed ID: 31423182
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCHE1 participates in postoperative distant recurrence but not local recurrence of osteosarcoma possibly by interacting with ROCK1.
Zhang Z; Yu T; Geng W
BMC Musculoskelet Disord; 2020 Jul; 21(1):462. PubMed ID: 32660450
[TBL] [Abstract][Full Text] [Related]
9. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.
Fan Y; Fan X; Yan H; Liu Z; Wang X; Yuan Q; Xie J; Lu X; Yang Y
Cell Death Dis; 2022 Feb; 13(2):157. PubMed ID: 35173149
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer cells.
Xu G; Zhang Y; Li N; Zhang JB; Xu R
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2631-2637. PubMed ID: 29771412
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
Xiao X; Li L; Cui JC; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451.
Shi L; Cong YZ; Wang ZJ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6187-6195. PubMed ID: 34730199
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
[TBL] [Abstract][Full Text] [Related]
20. The Long Non-Coding RNA ENST00000489676 Influences Papillary Thyroid Cancer Cell Proliferation and Invasion through Regulating MiR-922.
Wang W; Xia S; Zhan W
J Cancer; 2019; 10(22):5434-5446. PubMed ID: 31632488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
